BackgroundCheck.run
Search For

Peng Zhang, 55Washington, DC

Peng Zhang Phones & Addresses

Washington, DC   

Rockville, MD   

Wilton, CT   

Mentions for Peng Zhang

Peng Zhang resumes & CV records

Resumes

Peng Zhang Photo 35

Peng Zhang - Elmhurst, NY

Work:
Thakur Digital May 2014 to 2000
Photographer (part time)
United Inc. - Manhattan, NY Mar 2014 to Jul 2014
Cooperation Trainer (full time)
Buffalo Used Furniture - Buffalo, NY Jun 2013 to Feb 2014
Individual Founder (part time)
Campus Dining & Shop - Buffalo, NY Sep 2012 to Dec 2013
Campus Dining Attendant (part time)
Social Democrats, USA - Washington, DC Aug 2013 to Aug 2013
Volunteer Photographer
Rich Rose Shoes Factory Jan 2010 to Dec 2010
Production Manager (full time)
Wan Shun Shoes Store Jun 2009 to Dec 2009
Sales Representative (full time)
Education:
UNIVERSITY AT BUFFALO, THE STATE UNIVERSITY OF NEW YORK - Buffalo, NY 2011 to 2013
Bachelor of Science in Business Administration
Skills:
Microsoft Office Word, Excel, PowerPoint, Access, Photoshop, Photography, Marketing research and Marketing analysis, Organization and leadership, Social Media
Peng Zhang Photo 36

Peng Zhang - Silver Spring, MD

Work:
United Nation Association Aug 2012 to Aug 2012
Technical Support
School Intern May 2011 to Sep 2011 Beijing Willex Advanced Systems Ltd May 2009 to Sep 2009
Manager to run memory allocation
Hainan Province Power Company Jun 2007 to Sep 2007
Supervisory Control and Data Acquisition
Thermal Power Plants, Datang International Power Group Apr 2006 to Jun 2006
Education:
George Washington University - Washington, DC May 2012
Master in Electrical Engineering
North China Electric Power University Sep 2005 to Jun 2009
Bachelor of Science in Materials Science and Engineering

Publications & IP owners

Us Patents

Hiv-1 Envelope Protein Associated With A Broadly Reactive Neutralizing Antibody Response

US Patent:
7090848, Aug 15, 2006
Filed:
Aug 4, 1999
Appl. No.:
09/762261
Inventors:
Peng Fei Zhang - Bethesda MD, US
Assignee:
Henry M. Jackson Foundation for the Advancement of Military Medicine - Rockville MD
International Classification:
A61K 39/21
A61K 38/04
US Classification:
4241881, 4241991, 4242041, 530300, 530350, 530327, 530826
Abstract:
The present invention relates to HIV-1 envelope proteins from a donor with non-progressive HIV-1 infection whose serum contains broadly cross-reactive, primary virus neutralizing antibody. The invention also relates to isolated or purified proteins and protein fragments that share certain amino acids at particular positions with the foregoing HIV-1 proteins.

Hiv-1 Protein Associated With Broadly Reactive Neutralizing Antibody Response

US Patent:
7608688, Oct 27, 2009
Filed:
Jun 23, 2006
Appl. No.:
11/473036
Inventors:
Peng Fei Zhang - Bethesda MD, US
Assignee:
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. - Rockville MD
International Classification:
C07K 14/00
US Classification:
530350
Abstract:
The present invention relates to HIV-1 envelope proteins from a donor with non-progressive HIV-1 infection whose serum contains broadly cross-reactive, primary virus neutralizing antibody. The invention also relates to isolated or purified proteins and protein fragments that share certain amino acids at particular positions with the foregoing HIV-1 proteins.

Ultra-Scalable Supercomputer Based On Mpu Architecture

US Patent:
8159973, Apr 17, 2012
Filed:
Jul 25, 2008
Appl. No.:
12/179657
Inventors:
Yuefan Deng - Setauket NY, US
Alexander Korobka - Maywood NJ, US
Peng Zhang - Setauket NY, US
Assignee:
Shanghai Red Neurons Co., Ltd. - Shanghai
International Classification:
H04L 12/28
US Classification:
370254, 709249
Abstract:
The invention provides an ultra-scalable supercomputer based on MPU architecture in achieving the well-balanced performance of hundreds of TFLOPS or PFLOPS range in applications. The supercomputer system design includes the interconnect topology and its corresponding routing strategies, the communication subsystem design and implementation, the software and hardware schematic implementations. The supercomputer comprises a plurality of processing nodes powering the parallel processing and Axon nodes connecting computing nodes while implementing the external interconnections. The interconnect topology can be based on MPU architecture and the communication routing logic as required by switching logics is implemented in the FPGA chips while some modular designs for accelerating particular traffic patterns from applications and meliorating the communication overhead are able to be deployed as well.

Mixed Torus And Hypercube Multi-Rank Tensor Expansion Method

US Patent:
8510535, Aug 13, 2013
Filed:
Jun 19, 2008
Appl. No.:
12/141983
Inventors:
Yuefan Deng - Setauket NY, US
Peng Zhang - Setauket NY, US
Assignee:
Shanghai Redneurons Co., Ltd - Shanghai
International Classification:
G06F 15/76
US Classification:
712 11, 712 12
Abstract:
The present invention provides a mixed torus and hypercube multi-rank tensor expansion method which can be applied to the communication subsystem of a parallel processing system. The said expansion method is based on the conventional torus and hypercube topologies. A mixed torus and hypercube multi-rank tensor expansion interconnection network is built up by means of supernodes equipped with expansion interfaces. This method not only provides more bisection bandwidth to the entire system but also improves the long-range communication and global operations. Affirmatively, this expansion method can achieve better scalability and flexibility for the parallel system for a given system size.

Expression And Characterization Of Hiv-1 Envelope Protein Associated With Broadly Cross Reactive Neutralizing Antibody Response

US Patent:
2010008, Apr 1, 2010
Filed:
Sep 17, 2009
Appl. No.:
12/561455
Inventors:
Peng Fei Zhang - Bethesda MD, US
International Classification:
A61K 39/21
G01N 33/566
C07K 7/64
C07K 16/00
A61P 31/18
US Classification:
4241881, 530350, 4241841, 436501, 530321, 5303871
Abstract:
The present invention relates to HIV-1 envelope proteins from a donor with non-progressive HIV-1 infection whose serum contains broadly cross-reactive, primary virus neutralizing antibody. The invention also relates to isolated or purified proteins and protein fragments that share certain amino acids at particular positions with the foregoing HIV-1 proteins.

Recombinant Hiv-1 Envelope Proteins And Their Use

US Patent:
2019008, Mar 21, 2019
Filed:
Mar 9, 2017
Appl. No.:
16/083359
Inventors:
- Bethesda MD, US
Peng ZHANG - Rockville MD, US
Assignee:
The Unite States of America, as represented by the Secretary, Department of Health and Human Service - Bethesda MD
International Classification:
C07K 14/005
A61K 39/21
Abstract:
Embodiments of HIV-1 Env ectodomain trimers stabilized in a prefusion mature closed conformation and methods of their use and production are disclosed. Nucleic acid molecules encoding the HIV-1 Env ectodomain trimers are also provided. In several embodiments, the HIV-1 Env ectodomain trimers and/or nucleic acid molecules can be used to generate an immune response to HIV-1 in a subject, for example, to treat or prevent an HIV-1 infection in the subject.

Determining Stereoisomeric Excess, Concentration And Absolute Configuration

US Patent:
2018036, Dec 20, 2018
Filed:
Jun 8, 2018
Appl. No.:
16/004215
Inventors:
- Washington DC, US
Keith BENTLEY - Washington DC, US
Burcin IRFANOGLU - Lake Forest CA, US
Peng ZHANG - Arlington VA, US
International Classification:
G01N 31/10
G01N 21/19
Abstract:
The present invention is directed to analytical methods for determining the concentration, and/or stereoisomeric excess, and/or absolute configuration of chiral analytes in a sample.

Determining Stereoisomeric Excess, Concentration And Absolute Configuration

US Patent:
2018029, Oct 11, 2018
Filed:
Jun 8, 2018
Appl. No.:
16/004206
Inventors:
- Washington DC, US
Peng ZHANG - Arlington VA, US
International Classification:
G01N 31/10
G01N 21/19
Abstract:
The present invention is directed to analytical methods for determining the concentration, and/or stereoisomeric excess, and/or absolute configuration of chiral analytes in a sample.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.